Thromb Haemost 2021; 121(12): 1628-1636
DOI: 10.1055/a-1481-2663
Cellular Haemostasis and Platelets

Role of Membrane Lipid Rafts in MRP4 (ABCC4) Dependent Regulation of the cAMP Pathway in Blood Platelets

Tiphaine Belleville-Rolland*
1   Service d'hématologie biologique, AH-HP, Hopital Européen Georges Pompidou, Paris, France
2   Université de Paris, Innovative Therapies in Haemostasis, INSERM U1140, Paris, France
,
Alexandre Leuci*
2   Université de Paris, Innovative Therapies in Haemostasis, INSERM U1140, Paris, France
,
Alexandre Mansour
2   Université de Paris, Innovative Therapies in Haemostasis, INSERM U1140, Paris, France
,
Benoit Decouture
2   Université de Paris, Innovative Therapies in Haemostasis, INSERM U1140, Paris, France
,
Fanny Martin
2   Université de Paris, Innovative Therapies in Haemostasis, INSERM U1140, Paris, France
,
Sonia Poirault-Chassac
2   Université de Paris, Innovative Therapies in Haemostasis, INSERM U1140, Paris, France
,
Margot Rouaud
2   Université de Paris, Innovative Therapies in Haemostasis, INSERM U1140, Paris, France
,
Hippolyte Guerineau
2   Université de Paris, Innovative Therapies in Haemostasis, INSERM U1140, Paris, France
,
Blandine Dizier
2   Université de Paris, Innovative Therapies in Haemostasis, INSERM U1140, Paris, France
,
Dominique Pidard
2   Université de Paris, Innovative Therapies in Haemostasis, INSERM U1140, Paris, France
,
Pascale Gaussem**
1   Service d'hématologie biologique, AH-HP, Hopital Européen Georges Pompidou, Paris, France
2   Université de Paris, Innovative Therapies in Haemostasis, INSERM U1140, Paris, France
,
Christilla Bachelot-Loza**
2   Université de Paris, Innovative Therapies in Haemostasis, INSERM U1140, Paris, France
› Institutsangaben
Funding This study received funding from the Institut National de la Santé et de la Recherche Médicale, Promex Stiftung für die Forschung Foundation, Université de Paris.

Abstract

Background Platelet cytosolic cyclic adenosine monophosphate (cAMP) levels are balanced by synthesis, degradation, and efflux. Efflux can occur via multidrug resistant protein-4 (MRP4; ABCC4) present on dense granule and/or plasma membranes. As lipid rafts have been shown to interfere on cAMP homeostasis, we evaluated the relationships between the distribution and activity of MRP4 in lipid rafts and cAMP efflux.

Methods Platelet activation and cAMP homeostasis were analyzed in human and wild-type or MRP4-deleted mouse platelets in the presence of methyl-β-cyclodextrin (MßCD) to disrupt lipid rafts, and of activators of the cAMP signalling pathways. Human platelet MRP4 and effector proteins of the cAMP pathway were analyzed by immunoblots in lipid rafts isolated by differential centrifugation.

Results MßCD dose dependently inhibited human and mouse platelet aggregation without affecting per se cAMP levels. An additive inhibitory effect existed between the adenylate cyclase (AC) activator forskolin and MßCD that was accompanied by an overincrease of cAMP, and which was significantly enhanced upon MRP4 deletion. Finally, an efflux of cAMP out of resting platelets incubated with prostaglandin E1 (PGE1) was observed that was partly dependent on MRP4. Lipid rafts contained a small fraction (≈15%) of MRP4 and most of the inhibitory G-protein Gi, whereas Gs protein, AC3, and phosphodiesterases PDE2 and PDE3A were all present as only trace amounts.

Conclusion Our results are in favour of part of MRP4 present at the platelet surface, including in lipid rafts. Lipid raft integrity is necessary for cAMP signalling regulation, although MRP4 and most players of cAMP homeostasis are essentially located outside rafts.

Authors' Contributions

T.B.R. conceived the study, designed and performed the research, analyzed data and wrote the manuscript. A.L. participated in the research, analyzed data, and participated in writing the initial and revised versions of the manuscript. A.M., B.D., F.M., S.P.C., M.R., H.G., B.D., and C.B.L. performed research and, together with DP, revised the manuscript and gave final approval. C.B.L. and P.G. conceived the study, designed the research, analyzed data and wrote the manuscript.


* T.B.R. and A.L. share co-first authorship.


** P.G. and C.B.L. share co-senior authorship.


Supplementary Material



Publikationsverlauf

Eingereicht: 02. Oktober 2020

Angenommen: 12. April 2021

Publikationsdatum:
13. April 2021 (online)

© 2021. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany